--- title: "OneMedNet Corporation (NASDAQ:ONMD) Short Interest Up 45.8% in February" type: "News" locale: "en" url: "https://longbridge.com/en/news/277369873.md" description: "OneMedNet Corporation (NASDAQ:ONMD) experienced a 45.8% increase in short interest in February, totaling 326,990 shares as of February 13th. This rise from 224,270 shares on January 29th indicates that 1.2% of the company's shares are currently short sold, with a short-interest ratio of 1.2 days based on an average daily volume of 283,072 shares. Institutional investors have also made changes to their positions in ONMD, with a majority holding 0.95% of the stock. Analysts maintain a \"sell\" rating on the stock, which is currently trading at $1.02." datetime: "2026-03-01T20:42:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277369873.md) - [en](https://longbridge.com/en/news/277369873.md) - [zh-HK](https://longbridge.com/zh-HK/news/277369873.md) --- # OneMedNet Corporation (NASDAQ:ONMD) Short Interest Up 45.8% in February OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 13th, there was short interest totaling 326,990 shares, an increase of 45.8% from the January 29th total of 224,270 shares. Based on an average daily trading volume, of 283,072 shares, the short-interest ratio is presently 1.2 days. Approximately 1.2% of the shares of the company are short sold. Approximately 1.2% of the shares of the company are short sold. Based on an average daily trading volume, of 283,072 shares, the short-interest ratio is presently 1.2 days. ## Hedge Funds Weigh In On OneMedNet - Palantir’s New Healthcare Deal Boosts AI and Data Reach Several hedge funds and other institutional investors have recently made changes to their positions in ONMD. Ashton Thomas Private Wealth LLC acquired a new stake in OneMedNet in the 3rd quarter valued at approximately $25,000. HRT Financial LP bought a new position in shares of OneMedNet in the fourth quarter worth $32,000. Virtu Financial LLC acquired a new position in shares of OneMedNet during the fourth quarter valued at $48,000. Jane Street Group LLC acquired a new position in shares of OneMedNet during the fourth quarter valued at $119,000. Finally, State Street Corp raised its stake in shares of OneMedNet by 41.5% during the fourth quarter. State Street Corp now owns 116,700 shares of the company's stock valued at $128,000 after purchasing an additional 34,200 shares in the last quarter. 0.95% of the stock is currently owned by institutional investors and hedge funds. ## Wall Street Analysts Forecast Growth Separately, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of OneMedNet in a report on Friday, January 9th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of "Sell". **Read Our Latest Analysis on ONMD** ## OneMedNet Price Performance Shares of ONMD stock traded up $0.31 during trading hours on Friday, reaching $1.02. The stock had a trading volume of 216,755,443 shares, compared to its average volume of 216,853. The firm has a market capitalization of $52.03 million, a PE ratio of -20.40 and a beta of 1.13. The firm has a 50-day simple moving average of $0.92 and a 200-day simple moving average of $1.28. OneMedNet has a twelve month low of $0.30 and a twelve month high of $4.22. ## OneMedNet Company Profile (Get Free Report) OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota. ## Featured Stories - Five stocks we like better than OneMedNet - The gold chart Wall Street is terrified of… - This makes me furious - America’s 1776 happening again - Buy this Gold Stock Before May 2026 - “Fed Proof” Your Bank Account with THESE 4 Simple Steps _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in OneMedNet Right Now? Before you consider OneMedNet, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OneMedNet wasn't on the list. While OneMedNet currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [ONMDW.US](https://longbridge.com/en/quote/ONMDW.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [ONMD.US](https://longbridge.com/en/quote/ONMD.US.md) ## Related News & Research - [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md) - [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md) - [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md) - [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md) - [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)